Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Venetz

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Revue Medicale Suisse|April 4, 2013
[Renal glucosuria]A Rohfleisch, G Nseir, H Chehade, et al.
Revue Medicale Suisse|March 28, 2006
[Clinical and genetics aspects of Alport syndrome]D Golshayan, J P Venetz, F Cachat, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 19, 2007
Meningococcal disease in a kidney transplant recipient with mannose-binding lectin deficiencyO Manuel, P E Tarr, J-P Venetz, et al.
The British Journal of Dermatology|March 30, 2010
Giant warts in a kidney transplant patient: regression with sirolimusM Kostaki, J P Venetz, G Nseir, et al.
Transplantation Proceedings|April 26, 2005
Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovirJ Fellay, J-P Venetz, J-D Aubert, et al.
Scandinavian Journal of Immunology|November 7, 2001
Idiopathic membranous glomerulonephritis is associated with altered patterns of self-reactive IgM and IgG antibody repertoiresD Stahl, J P Venetz, S Lacroix-Desmazes, et al.
Transplantation Proceedings|December 23, 2018
Use of Intraoperative Duplex Ultrasound and Resistance Index Reduces Complications in Living Renal Donor TransplantationM Bejic, S Déglise, J P Venetz, et al.
Revue Medicale Suisse|April 29, 2015
[Transition in kidney transplantation]H Chehade, P Parvex, J-P Venetz, et al.
The Journal of Antimicrobial Chemotherapy|March 18, 2008
Disposition of valganciclovir during continuous renal replacement therapy in two lung transplant recipientsN Perrottet, C Robatel, P Meylan, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2009
Population pharmacokinetics of ganciclovir in solid-organ transplant recipients receiving oral valganciclovirN Perrottet, C Csajka, M Pascual, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Revue Medicale Suisse|April 4, 2013
[Renal glucosuria]A Rohfleisch, G Nseir, H Chehade, et al.
Revue Medicale Suisse|March 28, 2006
[Clinical and genetics aspects of Alport syndrome]D Golshayan, J P Venetz, F Cachat, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 19, 2007
Meningococcal disease in a kidney transplant recipient with mannose-binding lectin deficiencyO Manuel, P E Tarr, J-P Venetz, et al.
The British Journal of Dermatology|March 30, 2010
Giant warts in a kidney transplant patient: regression with sirolimusM Kostaki, J P Venetz, G Nseir, et al.
Transplantation Proceedings|April 26, 2005
Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovirJ Fellay, J-P Venetz, J-D Aubert, et al.
Scandinavian Journal of Immunology|November 7, 2001
Idiopathic membranous glomerulonephritis is associated with altered patterns of self-reactive IgM and IgG antibody repertoiresD Stahl, J P Venetz, S Lacroix-Desmazes, et al.
Transplantation Proceedings|December 23, 2018
Use of Intraoperative Duplex Ultrasound and Resistance Index Reduces Complications in Living Renal Donor TransplantationM Bejic, S Déglise, J P Venetz, et al.
Revue Medicale Suisse|April 29, 2015
[Transition in kidney transplantation]H Chehade, P Parvex, J-P Venetz, et al.
The Journal of Antimicrobial Chemotherapy|March 18, 2008
Disposition of valganciclovir during continuous renal replacement therapy in two lung transplant recipientsN Perrottet, C Robatel, P Meylan, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2009
Population pharmacokinetics of ganciclovir in solid-organ transplant recipients receiving oral valganciclovirN Perrottet, C Csajka, M Pascual, et al.
Pageof 3